RS10455872 POLYMORPHISM WITHIN THE LPA GENE IS ASSOCIATED WITH SEVERE BIOPROSTHETIC MITRAL VALVE CALCIFICATION
Main Article Content
Abstract
Background. Bioprosthetic mitral valves frequently undergo severe calcification causing bioprosthetic valve failure, an urgent problem in cardiovascular surgery. However, no research has been performed on genetic susceptibility to severe bioprosthetic mitral valve calcification.
Aim – to assess whether inherited variation in genes of lipid metabolism is associated with severe bioprosthetic mitral valve calcification.
Materials and methods. We recruited 124 consecutive patients who underwent mitral valve replacement surgery. We assessed six polymorphisms within the four genes: rs1042031 and rs6725189 (APOB gene), rs7412 and rs429358 (APOE gene), rs1800588 (LIPC gene) and rs10455872 (LPA gene). To perform an additional quality control step, we tested six non-relevant polymorphisms within the genes encoding coagulation factors and integrin beta 3, a protein responsible for platelet aggregation: rs1799963 (F2 gene), rs6025 and rs6027 (F5 gene), rs6046 (F7 gene), rs5985 (F13A1 gene) and rs5918 (ITGB3 gene). Genotyping was carried out in 96-well format using the TaqMan SNP genotyping assay.
Results. A/A genotype of the rs10455872 polymorphism within the LPA gene was associated with more than 5-fold increased risk of severe bioprosthetic mitral valve calcification compared to the A/G genotype.
Conclusion. Polymorphisms within the lipid metabolism genes may be associated with severe bioprosthetic mitral valve calcification.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Nishimura RA, Otto CM, Bonow RO et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology /American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63(22): e57-185
Bella JN, Tang W, Kraja A et al. Genome-wide linkage mapping for valve calcification susceptibility loci in hypertensive sibships: the Hypertension Genetic Epidemiology Network Study. Hypertension. 2007; 49(3): 453-460
Kutikhin AG, Yuzhalin AE, Brusina EB et al. Genetic predisposition to calcific aortic stenosis and mitral annular calcification. Mol Biol Rep. 2014; 41(9): 5645-5663
Yuzhalin AE, Kutikhin AG. Integrative systems of genomic risk markers for cancer and other diseases: future of predictive medicine. Cancer Manag Res. 2012; 4: 131-135
Bakhtiar SM, Ali A, Baig SM et al. Identifying human disease genes: advances in molecular genetics and computational approaches. Genet Mol Res. 2014; 13(3): 5073-5087
American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006; 48(3): e1-148
Astapov DA, Karas'kov AM, Semenova EI, Demidov DP. The mithral valve replacement with biological prostheses: early and long-term results. Khirurgiia (Mosk). 2013; 9: 18-23
Xu Z, Taylor JA. SNP info: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res. 2009; 37(Web Server issue): W600-605
Dayem Ullah AZ, Lemoine NR, Chelala C. SNPnexus: a web server for functional annotation of novel and publicly known genetic variants (2012 update). Nucleic Acids Res. 2012; 40(Web Server issue): W65-70
Solé X, Guinó E, Valls J et al. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006; 22(15):1928-1929
Novaro GM, Sachar R, Pearce GL et al. Association between apolipoprotein E alleles and calcific valvular heart disease. Circulation. 2003; 108(15): 1804-1808
Tangri N, Alam A, Wooten EC, Huggins GS. Lack of association of Klotho gene variants with valvular and vascular calcification in Caucasians: a candidate gene study of the Framingham Offspring Cohort. Nephrol Dial Transplant. 2011; 26(12): 3998-4002
Davutoglu V, Nacak M. Influence of angiotensin-converting enzyme gene insertion/deletion polymorphism on rheumatic valve involvement, valve severity and subsequent valve calcification. J Heart Valve Dis. 2005; 14(3): 277-281
Thanassoulis G, Campbell CY, Owens DS et al. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med. 2013; 368(6): 503-512
Clarke R, Peden JF, Hopewell JC et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009; 361(26): 2518-2528